My (half-) brother has Huntington's. It killed his father, so he knew it was possible and he's not having any children. He's just turned 30 and just had its presence confirmed, but apparently he'll be symptom-free until about 60. Hopefully we get more good news like this in the next 30 years.
Technology
This is a most excellent place for technology news and articles.
Our Rules
- Follow the lemmy.world rules.
- Only tech related news or articles.
- Be excellent to each other!
- Mod approved content bots can post up to 10 articles per day.
- Threads asking for personal tech support may be deleted.
- Politics threads may be removed.
- No memes allowed as posts, OK to post as comments.
- Only approved bots from the list below, this includes using AI responses and summaries. To ask if your bot can be added please contact a mod.
- Check for duplicates before posting, duplicates may be removed
- Accounts 7 days and younger will have their posts automatically removed.
Approved Bots
This is the kind of good news we need right now. Contact your local representatives and let them know that science works and that basic research funding is a priority for you, your community, and humanity.
A friend of mine carried the Huntington gene. He didn't get it, but all three of his kids are dead from it.
Was he aware of being a carrier of the gene before deciding to reproduce?
Asking the real questions.
That's awful...
Finally, news that isn't depressing
Seeing mrna technology to start to stride is one of the few solaces I have in this millenia.
A treatment that will be refused by MAHA, I assume. 😒
I knew a kid with that terrible disease. Wish it would have arrived 20 years ago.
This was not a clinical trial, it was a safety study of only 11 treated. No controls.
CEO of UniQure already dumped all his stock options.
It was a phase I\II trial. Dafuq u on about?
Phase I\II determine efficacy and safety profiles.
In this case they are proceeding with a new cohort where the administration will be concurrent with immune suppression to counteract inflammation in the pos-op phase.
They will likely apply for a phase III after since this is an orphan drug.